Minireviews
Copyright ©The Author(s) 2019.
World J Hepatol. Mar 27, 2019; 11(3): 250-260
Published online Mar 27, 2019. doi: 10.4254/wjh.v11.i3.250
Table 1 Risk of bleeding, mortality and complication rate according to treatment group[11]
CharacteristicsCyanoacrylate Group I(n = 30)PropranololGroup II(n = 29)No treatmentGroup III(n = 30)P value
GV bleed10%38%53%0.003
Bleed-related mortality010%24%0.034
Overall mortality7%17%26%0.113
Complications3%3%7%1